Neuronetics
Malvern, Pennsylvania, 19355, United States
Location status: Recruiting
Location contact
Eleanor Cole
CONTACT
NCT Number: NCT06997549
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
Interested in participating?
Request Info5 year–100 year
All sexes
Observational
Malvern, Pennsylvania, 19355, United States
Location status: Recruiting
Eleanor Cole
CONTACT
this is a retrospective data analysis study that will utilize the already collected data as clinical care and will help understand the utilization and efficacy of various treatment options available for various mental heath conditions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
non-invasive brain stimulation device
Other names: TMS
nasal spray for treating depression
Other names: spravato
Time frame: 8 weeks
real-world efficacy of NeuroStar TMS as compared to Esketamine in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9
Contact information is provided by the study sponsor or research team.
Eleanor Cole, PhD
CONTACT
Neha Goyal
CONTACT
Neuronetics
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05658796
Anxiety, Anxiety Depression
Monroeville, Pennsylvania, United States
View Trial DetailsNCT06917339
Anxiety Depression, Anxiety Disorders
Malvern, Pennsylvania, United States
View Trial DetailsNCT04982757
Behavior, Behavioral Symptoms
New York, United States
View Trial DetailsNCT06282146
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial Details